GlassScriptPhysician profile
Naveen Divakaruni
NPI 1386801751
$8,555.84
in general payments reported to CMS, 2019-2025
17 companies · $940 in 2025
The $940 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $962 · 2020: $17.66 · 2021: $144 · 2022: $311 · 2023: $201 · 2024: $5,981 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,000 · Food and Beverage: $1,928 · Travel and Lodging: $179 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,000.00 |
| Food and Beverage | $1,927.99 |
| Travel and Lodging | $178.88 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $5,210.37 | 2021-2024 | Speedicath |
| Teleflex LLC | $1,229.53 | 2021-2025 | Urolift, Barrigel |
| Neotract INC. | $934.40 | 2019-2020 | |
| Procept Biorobotics Corporation | $422.45 | 2025 | |
| Antares Pharma, INC. | $168.98 | 2022-2024 | Xyosted |
| Laborie Medical Technologies Corp. | $136.52 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Boston Scientific Corporation | $127.64 | 2019-2025 | Ams 800 Artificial Urinary Sphincter, General - Kidney Stone Disease |
| Bluewind Medical | $69.92 | 2024 | Revi |
| Dendreon Pharmaceuticals LLC | $69.63 | 2025 | Provenge |
| Abbvie INC. | $45.86 | 2022 | |
| Ambu INC. | $43.39 | 2021-2022 | |
| Olympus America INC. | $20.25 | 2023 | Olympus |
| Blue Earth Diagnostics | $19.23 | 2021 | |
| Urogen Pharma, INC. | $16.62 | 2025 | |
| Pfizer INC. | $14.63 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $13.58 | 2023 | |
| Cook Medical LLC | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naveen Divakaruni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.